May Y. Choi

Associate Professor

Division of Rheumatology

Rheumatologist

Richmond Road Diagnostic and Treatment Centre

Associate Director, Translational Research

Lupus Centre of Excellence

Research Representative

Executive Committee

Masters in Public Health in Epidemiology

Harvard University

Brigham and Women’s Hospital Lupus Fellowship

Harvard University

Adult Rheumatology Fellowship

University of Calgary

Residency, Internal Medicine

University of Calgary

MD

University of Alberta

Contact information


Preferred method of communication

Please contact Dr. Choi’s assistants Katherine Buhler for research inquiries and Danielle Giesbrecht  for clinical inquiries.


Areas of focus

Research areas

  • Diagnostics biomarkers for autoimmune diseases
  • Autoantibodies
  • Epidemiology
  • Machine learning
  • Lupus

Biography

Dr. May Choi is a graduate of the Cumming School of Medicine’s Adult Rheumatology training program. She’s also the Associate Director of MitogenDx and the Associate Director of Translational Research at the Lupus Centre of Excellence.  Dr. Choi completed her Bachelor of Health Sciences (Honours) degree at the University of Calgary in 2010, her Doctor of Medicine at the University of Alberta in 2014 and Internal Medicine training at the University of Calgary in 2017.

In 2019, she began a Masters of Public Health in Epidemiology Program at Harvard University and the Brigham and Women’s Hospital Lupus Fellowship under the supervision of Dr. Karen Costenbader.

Her recent publications and current research interests are focused on biomarker discovery and validation for the prediction of clinical outcomes in early onset lupus, as well as systemic lupus erythematosus (SLE) epidemiology.

Current research projects:

  • Longitudinal Examination of ANA and Novel Autoantibodies in SLE
    • In collaboration with Harvard and MIT.
  • COVID-19 Biomarker Projects in SLE Patients
  • Nurses Health Study for SLE and Rheumatoid Arthritis
  • Cardiovascular Risk Prediction Models in SLE
  • Hydroxychloroquine Toxicity in Autoimmune Patients